“…28 L-Methylfolate has not been studied in reducing morbidity associated with cardiovascular disease, but it has demonstrated a significant improvement in endothelial function and vasodilation. [29][30][31][32] Regarding the potential association between folate and decline in cognition, folic acid dosed at 800 µg or greater leads to unmetabolized folic acid in the serum, 33,34 which can reduce the amount of L-methylfolate that reaches the brain, thus leading to toxic complications, 35,36 reduction in monoamines, 37 and a potential increase in depression. 38 L-Methylfolate is able to cross the blood-brain barrier [39][40][41] and may therefore be safer in elderly populations in whom cognition decline may be a concern; it may also be less likely to result in other toxic complications such as the reduction of natural killer cell cytotoxicity in postmenopausal women.…”